0 followers
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as many cancers use the TME to build barriers that shield immune syste... Read more
Laurent Audoly
Kyverna Therapeutics
6 followers
Cellares
2 followers
Arbor Biotechnologies
2 followers
Trevi Therapeutics
1 follower
School District of Philadelphia
4 followers
Bezos Academy
3 followers
Watchmaker Genomics
3 followers
Hillevax
2 followers
Ultima Genomics
3 followers
QurAlis
1 follower
Tempus Labs
17 followers
Explore companies